These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30110925)

  • 1. Differentiation of Human Tonsil-Derived Mesenchymal Stem Cells into Schwann-Like Cells Improves Neuromuscular Function in a Mouse Model of Charcot-Marie-Tooth Disease Type 1A.
    Park S; Jung N; Myung S; Choi Y; Chung KW; Choi BO; Jung SC
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30110925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of differentiated human tonsil-derived stem cells to trembler-J mice.
    Park S; Choi Y; Kwak G; Hong YB; Jung N; Kim J; Choi BO; Jung SC
    Muscle Nerve; 2018 Mar; 57(3):478-486. PubMed ID: 28796340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tonsil-Derived Mesenchymal Stem Cells Differentiate into a Schwann Cell Phenotype and Promote Peripheral Nerve Regeneration.
    Jung N; Park S; Choi Y; Park JW; Hong YB; Park HH; Yu Y; Kwak G; Kim HS; Ryu KH; Kim JK; Jo I; Choi BO; Jung SC
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
    Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
    Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the Pathogenesis of Charcot-Marie-Tooth Disease Type 1A Using Patient-Specific iPSCs.
    Shi L; Huang L; He R; Huang W; Wang H; Lai X; Zou Z; Sun J; Ke Q; Zheng M; Lu X; Pei Z; Su H; Xiang AP; Li W; Yao X
    Stem Cell Reports; 2018 Jan; 10(1):120-133. PubMed ID: 29276154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S; Scherer SS; Nave KA; Suter U
    J Neurosci Res; 2002 Feb; 67(4):443-9. PubMed ID: 11835311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells.
    Prior R; Silva A; Vangansewinkel T; Idkowiak J; Tharkeshwar AK; Hellings TP; Michailidou I; Vreijling J; Loos M; Koopmans B; Vlek N; Agaser C; Kuipers TB; Michiels C; Rossaert E; Verschoren S; Vermeire W; de Laat V; Dehairs J; Eggermont K; van den Biggelaar D; Bademosi AT; Meunier FA; vandeVen M; Van Damme P; Mei H; Swinnen JV; Lambrichts I; Baas F; Fluiter K; Wolfs E; Van Den Bosch L
    Brain; 2024 Sep; 147(9):3113-3130. PubMed ID: 38743588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy.
    Nobbio L; Fiorese F; Vigo T; Cilli M; Gherardi G; Grandis M; Melcangi RC; Mancardi G; Abbruzzese M; Schenone A
    J Neuropathol Exp Neurol; 2009 May; 68(5):441-55. PubMed ID: 19525893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
    Lee JS; Lee JY; Song DW; Bae HS; Doo HM; Yu HS; Lee KJ; Kim HK; Hwang H; Kwak G; Kim D; Kim S; Hong YB; Lee JM; Choi BO
    Nucleic Acids Res; 2020 Jan; 48(1):130-140. PubMed ID: 31713617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy.
    Hantke J; Carty L; Wagstaff LJ; Turmaine M; Wilton DK; Quintes S; Koltzenburg M; Baas F; Mirsky R; Jessen KR
    Brain; 2014 Nov; 137(Pt 11):2922-37. PubMed ID: 25216747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
    Chumakov I; Milet A; Cholet N; Primas G; Boucard A; Pereira Y; Graudens E; Mandel J; Laffaire J; Foucquier J; Glibert F; Bertrand V; Nave KA; Sereda MW; Vial E; Guedj M; Hajj R; Nabirotchkin S; Cohen D
    Orphanet J Rare Dis; 2014 Dec; 9():201. PubMed ID: 25491744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Efficacy of Peripheral Nerve Regeneration by Schwann Cell-like Cells Differentiated from Human Tonsil-Derived Mesenchymal Stem Cells in C22 Mice.
    Nam YH; Park S; Yum Y; Jeong S; Park HE; Kim HJ; Lim J; Choi BO; Jung SC
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
    Hanemann CO; Müller HW
    Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy.
    Scurry AN; Heredia DJ; Feng CY; Gephart GB; Hennig GW; Gould TW
    J Neuropathol Exp Neurol; 2016 Apr; 75(4):334-46. PubMed ID: 26921370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A.
    Massa R; Palumbo C; Cavallaro T; Panico MB; Bei R; Terracciano C; Rizzuto N; Bernardi G; Modesti A
    Muscle Nerve; 2006 Mar; 33(3):342-9. PubMed ID: 16307437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease.
    Fornasari BE; Ronchi G; Pascal D; Visigalli D; Capodivento G; Nobbio L; Perroteau I; Schenone A; Geuna S; Gambarotta G
    Exp Biol Med (Maywood); 2018 Feb; 243(4):370-374. PubMed ID: 29350067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
    Sancho S; Young P; Suter U
    Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
    Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot-Marie-Tooth disease type 1A.
    Ha N; Choi YI; Jung N; Song JY; Bae DK; Kim MC; Lee YJ; Song H; Kwak G; Jeong S; Park S; Nam SH; Jung SC; Choi BO
    Br J Pharmacol; 2020 Nov; 177(22):5096-5113. PubMed ID: 33460073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.